- Patent Title: Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors
-
Application No.: US16289612Application Date: 2019-02-28
-
Publication No.: US10507201B2Publication Date: 2019-12-17
- Inventor: Nicole Buschmann , Robin Alec Fairhurst , Pascal Furet , Diana Graus Porta , Carolina Haefliger , Bo Han , Thomas Knöpfel , Catherine Leblanc , Lv Liao , Robert Mah , Masato Murakami , Pierre Nimsgern , Michael Palmer , Dale Porter , Sebastien Ripoche , Can Wang , Youzhen Wang , Andreas Weiss , Jing Xiong , Xianglin Zhao
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH Basel
- Agency: Rimôn, P.C.
- Priority: WOPCT/CN2014/088094 20141003
- Main IPC: A61K31/475
- IPC: A61K31/475 ; A61K31/4545 ; A61K31/496 ; A61K31/55 ; A61P35/00 ; A61K31/4375
Abstract:
The present invention relates to therapeutic uses of compounds of formula (I) or a pharmaceutically acceptable salt thereof
Public/Granted literature
- US20190231760A1 USE OF RING-FUSED BICYCLIC PYRIDYL DERIVATIVES AS FGFR4 INHIBITORS Public/Granted day:2019-08-01
Information query
IPC分类:
